The "Canine Oral Chewable Tablets Market - Global Forecast 2026-2032" report has been added to ResearchAndMarkets.com's offering. The canine oral chewable tablets market is evolving as pet owner ...
Launches of Tuzulby® methylphenidate prolonged-release chewable tablets and Paxneury® guanfacine prolonged-release tablets, also in 5mg, 6mg, and 7mg strengthsTwo differentiated treatments exemplify ...
German CNS-focused specialist Neuraxpharm Group announced the launches in Europe of Tuzulby (methylphenidate hydrochloride) prolonged-release chewable tablets and Paxneury (guanfacine) ...
Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) is the first and only canine oral parasiticide to protect against six parasites, including fleas, ticks, ...
Conditional Approval Marks Elanco's Third New World Screwworm Treatment Option for Companion Animals, Providing Multiple Treatment Solutions Prior to Fly Being Detected in the U.S. FDA's Conditional ...
What Are Simparica Products for Fleas, Ticks, and Heartworms? The Simparica line of products (manufactured by Zoetis) includes chewable tablets (products that are given by mouth) for the prevention, ...
Made for children six years of age and older, Mighty Chews Cold & Flu is available in a mixed berry flavor in a daytime and nighttime format. CDC: H1N1 virus expected to make a large impact on ...
INDIANAPOLIS, Ind., Oct. 27, 2025 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) today announced label expansions for two of its leading canine prescription parasiticides, Credelio ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback